Her 2 Amplification | List of Frontiers open access articles

Case Report

Published on 29 May 2020

Metastatic Breast Cancer Coexisting With HER-2 Amplification and EGFR Exon 19 Deletion Benefits From EGFR-TKI Therapy: A Case Report

in Molecular and Cellular Oncology

Wei Jing
Jie-Tao Ma
Cheng-Bo Han

Frontiers in Oncology

doi 10.3389/fonc.2020.00771

6,540 views
3 citations

Case Report

Published on 25 Feb 2021

Case Report: Trastuzumab Treatment in Adenosquamous Carcinoma of the Extrahepatic Biliary Tract With Her-2 Amplification

in Gastrointestinal Cancers

Ye Hong
Xiaofen Li
Dan Cao

Frontiers in Oncology

doi 10.3389/fonc.2021.538328

3,531 views
10 citations

Case Report

Published on 20 Feb 2025

Disitamab vedotin combined with pyrotinib as salvage treatment in Her-2-amplified treatment refractory metastatic colorectal cancer: a case report

in Pharmacology of Anti-Cancer Drugs

Jianxin Chen
Jian Wang
Qinhong Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1431422

1,838 views
1 citation

Case Report

Published on 12 Feb 2025

Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy

in Cancer Immunity and Immunotherapy

Huanhuan Li
Chao Ren
Donghai Cui
Tao Wu
Zhiyong Nie

Frontiers in Immunology

doi 10.3389/fimmu.2025.1555074

3,658 views

Original Research

Published on 10 Jan 2022

The Value of Perioperative Chemotherapy for Patients With Hepatoid Adenocarcinoma of the Stomach Undergoing Radical Gastrectomy

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Kai Zhou
Anqiang Wang
Jingtao Wei
Ke Ji
Zhongwu Li
Xin Ji
Tao Fu
Ziyu Jia
Xiaojiang Wu
Ji Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.789104

3,772 views
15 citations

Case Report

Published on 08 Dec 2022

Patients with positive HER-2 amplification advanced gastroesophageal junction cancer achieved complete response with combined chemotherapy of AK104/cadonilimab (PD-1/CTLA-4 bispecific): A case report

in Cancer Immunity and Immunotherapy

Jieqiong Peng
Qiang Zhu
Ziru Peng
Zhen Chen
Yuantao Liu
Bo Liu

Frontiers in Immunology

doi 10.3389/fimmu.2022.1049518

8,377 views
17 citations

Articles

Metastatic Breast Cancer Coexisting With HER-2 Amplification and EGFR Exon 19 Deletion Benefits From EGFR-TKI Therapy: A Case Report

Case Report: Trastuzumab Treatment in Adenosquamous Carcinoma of the Extrahepatic Biliary Tract With Her-2 Amplification

Disitamab vedotin combined with pyrotinib as salvage treatment in Her-2-amplified treatment refractory metastatic colorectal cancer: a case report

Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy

The Value of Perioperative Chemotherapy for Patients With Hepatoid Adenocarcinoma of the Stomach Undergoing Radical Gastrectomy

Patients with positive HER-2 amplification advanced gastroesophageal junction cancer achieved complete response with combined chemotherapy of AK104/cadonilimab (PD-1/CTLA-4 bispecific): A case report